[Problem] To provide a method for manufacturing a siliceous film above a substrate having grooves. [Means for Solution] To provide a method for manufacturing a siliceous film, comprising the following steps: (a) a step of applying a siliceous film composition above a substrate having grooves to form a composition layer; (b) a step of exposing the composition layer to an atmosphere containing a basic compound gas and water vapor; and (c) a step of heating the substrate to cure the composition layer, wherein the basic compound is ammonia, a quaternary ammonium compound or a combination of any of these.
The present invention relates to liquid-crystalline (LC) media and to energy saving liquid-crystal displays (LCDs) containing these media, especially to displays addressed by an active matrix and in particular to LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
3.
ACCEPTOR-SUBSTITUTED EUV PAGS WITH HIGH ELECTRON AFFINITY
121a2a121a2a2a are independently selected from nitro, cyano, and an alkylsulfonyl, and X- is not a halide, tosylate, trifluoromethylsulfonate, tetrafluoroborate, an aryl-substituted borates, hexafluorophosphate, hexafluoroarsenate, acetate, trifluoroacetate, methane sulfonate, C-2 to C-20 linear unsubstituted alkyl sulfonates, naphthalenesulfonate, and camphorsulfonate. Also described are EUV negative and positive chemically amplified photoresist compostions containing said compound and the process of using these photoresist to pattern a substrate.
C08F 2/50 - Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
C08G 59/68 - Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups characterised by the catalysts used
C08G 65/10 - Saturated oxiranes characterised by the catalysts used
4.
STABLE LIQUID FORMULATIONS COMPRISING (6S)-5-METHYLTETRAHYDROFOLIC ACID OR SALTS THEREOF
The present invention relates to stable liquid formulations comprising (6S)-5-methyltetrahydro- folic acid or salts thereof, to a process for obtaining the same, and to the use of such stable liquid formulations as liquid vitamin preparations or as ingredient in liquid vitamin preparations.
The present invention relates to a dihydronaphthalene derivative of formula D as specified in claim 1, to a liquid crystal medium comprising a compound of formula D and to high-frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g. phased array antennas.
C09K 19/18 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
6.
BLOCK COPOLYMER FORMULATION FOR THE IMPROVEMENT OF SELF-ASSEMBLED MORPHOLOGY IN DIRECTED SELF-ASSEMBLY APPLICATION
ww which ranges from about 2,500 g/mole to about 8,000 g/mole, a polydispersity from about 1.20 to about 1.80, and further is selected from the group consisting a styrenic homopolymer prepared by radical polymerization, a styrenic random copolymer prepared by radical polymerization, whose repeat units only consist of styrenic repeat and where at least two styrenic repeat units are present, and a mixture of said styrenic homopolymer and at least one styrenic random copolymer. Also described are DSA processing methods using this composition.
C08F 297/02 - Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer using a catalyst of the anionic type
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
G03F 7/40 - Treatment after imagewise removal, e.g. baking
H01L 21/027 - Making masks on semiconductor bodies for further photolithographic processing, not provided for in group or
The present invention relates to cell culture media comprising N-norvalyl-L- tyrosine. The poor solubility of tyrosine in cell culture media is overcome by substituting it partially or fully with N-norvalyl-L-tyrosine.
The present application relates to a specific fluorene derivative, to its use in an electronic device and to an electronic device comprising said fluorene derivatives. Further, the present application relates to a process for the preparation of such fluorene compounds.
C07C 211/39 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
H10K 85/60 - Organic compounds having low molecular weight
The present invention relates to an organic electroluminescent device (OLED) comprising two adjacent light emitting layers, which are vertically stacked on top of each other. The present invention also relate to a tandem organic electroluminescent device.
H10K 85/60 - Organic compounds having low molecular weight
H10K 50/13 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers specially adapted for multicolour light emission, e.g. for emitting white light comprising stacked EL layers within one EL unit
H10K 101/00 - Properties of the organic materials covered by group
An electrocaloric device based on a liquid material suitable for cooling and heat management. The liquid crystalline material designated for the device is operated in or in vicinity of the ferroelectric nematic phase. The device has broad operating temperature, high induced temperature change, while requiring modest electric field strengths.
PATTERNED SUBSTRATE PRE-WETTING COMPOSITION, USE OF PRE-WETTING COMPOSITION FOR APPLICATION DIRECTLY ONTO PATTERNED SUBSTRATE, METHOD FOR MANUFACTURING RESIST PATTERN, METHOD FOR MANUFACTURING PROCESSED SUBSTRATE, AND METHOD FOR MANUFACTURING DEVICE
A patterned substrate pre-wetting composition includes 0.05 to 40 mmHg of vapor pressure at 20°C, and 15 to 60 dyn / cm of surface tension at 20°C. Viscosity of the patterned substrate pre-wetting composition at 20°C is 0.5 to 20.0 cP. The patterned substrate pre-wetting composition contains an organic solvent (A), and optionally, the organic solvent (A) is one organic solvent or a mixture of two or more organic solvents.
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
G03F 7/09 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers
The present disclosure relates to VHH-based NKp46 binders with favorable characteristics. Moreover, the present disclosure relates to pharmaceutical compositions comprising such a compound and the use of such compounds and such pharmaceutical compositions in medical treatment methods.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
The present invention relates to a method for preparing a composite, comprising at least the following steps (a) to (e): (a) providing a formulation onto a surface of a substrate; (b) applying baking at a starting temperature to the formulation; (c) increasing the temperature of the baking from the starting temperature to the 2nd temperature in the range from 100°C to 400°C; (d) optionally keeping the 2nd temperature; and (e) terminating the baking to obtain a composite.
C23C 18/12 - Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coating; Contact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
A system and method for quantifying the stray light that enters a Raman optical sensor and removes this from the Raman spectrum is disclosed. One or more background noise measurements are performed by the Raman analyzer wherein the laser is disabled during these background noise measurements. One or more traditional signal acquisition measurements are then performed. The results from the background noise measurements and the traditional signal acquisition measurement are then processed. This results in a clean spectrum, where the background noise has been significantly reduced. In some embodiments, background noise measurements are performed before and after the traditional signal acquisition measurement and these noise measurements are averaged.
The present invention relates to heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said heterocycles.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
The present application relates to a conductivity/resistivity cell, preferably for use in a water purification system, to a water purification system provided with the conductivity/resistivity cell, and to a method of determining the conductivity and/or resistivity of a sample liquid.
A system, method, and computer-readable medium for providing dietary recommendations using knowledge graphs are provided. In some implementations, the method may include querying a knowledge graph with at least one query parameter to receive a plurality of dish identifiers. In addition, the method may include scoring the plurality of dish identifiers in accordance with at least one dietary-preference parameter and at least one historical recommendation dish to thereby achieve a diabetic diet in accordance with the at least one dietary-preference parameter. The method may include sorting the plurality of dish identifiers in accordance with each respective score of the plurality of dish identifiers. Moreover, the method may include providing at least one recommendation dish to a user from a predetermined number of dish identifiers from the plurality of dish identifiers.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 70/20 - ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
18.
NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to nitrogenous heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
C07F 9/6584 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
H10K 85/00 - Organic materials used in the body or electrodes of devices covered by this subclass
C09K 11/00 - Luminescent, e.g. electroluminescent, chemiluminescent, materials
19.
ELECTRONIC DEVICE MANUFACTURING AQUEOUS SOLUTION, METHOD FOR MANUFACTURING RESIST PATTERN AND METHOD FOR MANUFACTURING DEVICE
To provide an electronic device manufacturing aqueous solution capable of suppressing defects. To provide an electronic device manufacturing aqueous solution comprising a sulfonic acid derivative (A) having a certain structure, a solvent (B) comprising water and a hydroxy derivative (C) having a certain structure.
B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. (Israel)
Inventor
Seim, Henning
Chashchikhin, Oleg
Lidich, Nina
Arbell, Hagai
Holtzman, Amir
Berkefeld, Andreas
Weinstock, Ira
Leffler, Nitai
Schreiber, Roy
Abstract
The present invention relates to a formulation for preparing an optical metal oxide layer, the formulation comprising polyoxometalates (POMs) complexed to metal oxide nanoparticles (NPs); a method for preparing an optical metal oxide layer using said formulation; and an optical device comprising said optical metal oxide layer.
To provide an electronic device manufacturing aqueous solution capable of suppressing defects. To provide an electronic device manufacturing aqueous solution comprising a sulfonic acid derivative (A) having a certain structure, a solvent (B) comprising water and a hydroxy-containing compound (C) having a certain structure.
The present invention relates to mono or bi-specific antibodies, or antibody fragments or fusion proteins thereof, capable of binding to the VHL ligand VH032 (or a derivative thereof) degrading moiety (degron) of a proteolysis targeting chimera (PROTAC) and, optionally, to a target protein. The invention also relates to complexes (PAX) of such antibodies, or antibody fragments or fusion proteins thereof, and PROTACS, as well as methods for their production, and medical as well as non-medical uses each thereof.
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
C07K 16/44 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere
The present invention describes a composition comprising a hole-transporting host material, an electron-transporting host material, and a phosphorescent metal complex as well as devices comprising these compositions, especially OLED including an emission layer comprising these compositions.
C07B 59/00 - Introduction of isotopes of elements into organic compounds
C07C 211/61 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
The present invention relates to novel compounds and organic electroluminescent devices such as OLEDs (organic light emitting diodes) that contain these compounds, for example as electron transport materials and/or matrix materials, optionally combined with another matrix material. The invention also relates to mixtures and formulations that contain these novel compounds.
C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 403/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
C07D 407/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
C07D 409/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
The present application relates to an electronic device, preferably an OLED, which is characterized in that it comprises two stacks of layers, where both stacks of layers share a layer. The application also applies to a method of preparing such electronic device, and to a mixture which can be used for preparing such electronic device.
The present invention relates to liquid-crystalline (LC) and to liquid-crystal displays (LCDs) containing these media, especially to displays addressed by an active matrix and in particular to LC energy saving displays of the TN, PS-TN, STN, TN- TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB- FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type.
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
28.
SUBSTRATE CLEANING COMPOSITION, AND USING THE SAME, METHOD FOR MANUFACTURING CLEANED SUBSTRATE AND METHOD FOR MANUFACTURING DEVICE
The present invention relates to compounds that are suitable for use in electronic devices, and to electronic devices, more particularly organic electroluminescent devices, containing these compounds.
The present invention relates to a liquid-crystal (LC) material as defined in claim (1), having negative dielectric anisotropy and to the use thereof for optical, electro-optical and electronic purposes, such as for example in LC displays, in particular energy saving displays based on the ECB, IPS or FFS effect.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
The present invention relates to a liquid-crystal (LC) material as defined in claim 1, having negative dielectric anisotropy and to the use thereof for optical, electro-optical and electronic purposes, such as for example in LC displays, in particular energy saving displays based on the ECB, IPS or FFS effect.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/14 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
The present invention relates to compounds of a formula (I) or (II), processes for preparing compounds of this type, electronic devices, in particular OLEDs, containing one or more of these compounds, and the use of these compounds in electronic devices, in particular in OLEDs.
C07D 407/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
The present invention relates to a novel process for producing fluorinated polymers, to novel fluorinated polymers produced by the process, to formulations containing the polymers and to the use of the polymers and formulations, in particular as surfactants or surface-active additives in formulations for coatings, and to articles coated with the polymers or formulations.
C08G 65/22 - Cyclic ethers having at least one atom other than carbon and hydrogen outside the ring
C08G 65/26 - Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
C08G 65/10 - Saturated oxiranes characterised by the catalysts used
A substrate treatment solution including a solidification component, wherein at least either the following condition (i) or condition (ii) is satisfied: (i) the solidification component is a plastic crystal compound having a melting point of 20 °C or more and 200 °C or less, and (ii) the substrate treatment solution further includes a surface modification component.
The present invention relates to liquid-crystalline (LC) media and to liquid-crystal displays (LCDs) containing these media, especially to energy saving displays addressed by an active matrix and in particular to LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability at lower temperatures and are highly suitable for use in automotive and outdoor applications.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/18 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
36.
MANUFACTURING OF A PHARMACEUTICAL DOSAGE FORM WITH 3D MELT DOSING
The invention relates to the use of a polymer for the manufacturing of a pharmaceutical dosage form with 3D melt dosing and a process for manufacturing of a pharmaceutical dosage form with 3D melt dosing using a polymer including the pharmaceutical dosage form obtainable by such a process.
The present invention concerns a device and a method for sample preparation, more specifically for sample concentration, in particular for microorganism sample concentration for microbial testing purposes.
B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
B01D 24/00 - Filters comprising loose filtering material, i.e. filtering material without any binder between the individual particles or fibres thereof
The present invention relates to a formulation containing at least one organic functional material and at least one organic solvent, preferably at least two different organic solvents, characterized in that at least one organic solvent is a deuterated solvent having a degree of deuteration of at least 25%, preferably at least 50%, more preferably at least 75% and most preferably 90%, to a process for the preparation of an electroluminescent device using the formulation of the present invention as well as to an electroluminescent device prepared by using the formulation of the present invention.
A manifold assembly for tangential flow filtration includes a center manifold, at least one end cap, and at least one gasket disposed between the center manifold and the at least one end cap. The center manifold and the at least one end cap may be injection molded, and the at least one end cap may be removably coupled to the center manifold. At least one compression limiter may be at least partially captured within the center manifold, and at least one compression pin may be at least partially captured within the end cap. The combination of the at least one compression limiter and the at least one compression pin enable the manifold assembly to be clamped within a clamping arrangement. The center manifold may further include a feed port, a drain port, a retentate port, and a filtrate port that are disposed on the same side of the center manifold.
C07C 253/20 - Preparation of carboxylic acid nitriles by dehydratation of carboxylic acid amides
C07C 255/52 - Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of six-membered aromatic rings being part of condensed ring systems
C07C 231/10 - Preparation of carboxylic acid amides from compounds not provided for in groups
C07C 233/65 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
41.
ORGANIC ELECTRONIC DEVICE AND SPECIAL MATERIALS FOR ORGANIC ELECTRONIC DEVICES
The invention relates to an organic electronic device comprising an anode, a cathode, and at least one light-emitting layer containing at least one 4H-naphtho[1,2,3,4-de/]carbazole and an additional matrix material, to special 4H-naphtho[1,2,3,4-de/]carbazole derivatives, to mixtures and formulations containing same, and to electronic devices containing said special 4H-naphtho[1,2,3,4-de/]carbazole derivatives, in particular organic electroluminescent devices or OLEDs containing said compounds, as matrix materials, hole transport materials, hole injection materials, or electron blocking materials.
The present application relates to a valve assembly (10) for a liquid dispensing unit and to a liquid dispensing unit for a water purification system as well as to a water purification system as such.
F16K 3/06 - Gate valves or sliding valves, i.e. cut-off apparatus with closing members having a sliding movement along the seat for opening and closing with flat sealing faces; Packings therefor with pivoted closure members in the form of closure plates arranged between supply and discharge passages
F16K 3/34 - Arrangements for modifying the way in which the rate of flow varies during the actuation of the valve
43.
MANIFOLD FOR A LIQUID TANK AND WATER PURIFICATION SYSTEM
The invention relates to a manifold for a liquid tank, preferably for use in a water purification system, and to a water purification system provided with the manifold.
G01F 23/14 - Indicating or measuring liquid level or level of fluent solid material, e.g. indicating in terms of volume or indicating by means of an alarm by measurement of pressure
G01F 23/18 - Indicating, recording, or alarm devices actuated electrically
C02F 103/04 - Non-contaminated water, e.g. for industrial water supply for obtaining pure or ultra-pure water
E03B 7/07 - Arrangement of devices, e.g. filters, flow controls, measuring devices, siphons, valves, in the pipe systems
G01L 9/00 - Measuring steady or quasi-steady pressure of a fluid or a fluent solid material by electric or magnetic pressure-sensitive elements; Transmitting or indicating the displacement of mechanical pressure-sensitive elements, used to measure the steady or quasi-steady pressure of a fluid or fluent solid material, by electric or magnetic means
G01L 19/00 - MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE - Details of, or accessories for, apparatus for measuring steady or quasi-steady pressure of a fluent medium insofar as such details or accessories are not special to particular types of pressure gauges
To provide a polysiloxane composition capable of forming a low dielectric constant film having a mechanical strength. A polysiloxane composition comprising: (I) a polysiloxane, (II) an ionic liquid, (III) an acid, and (IV) a solvent, in which the mixing ratio ((II)/(III)) of the ionic liquid (II) to the acid (III) is 0.001 to 0.09 at an equivalent ratio.
The present invention relates to a method for inactivating enveloped viruses by treatment with non-ionic surfactants, namely secondary fatty alcohol ethoxylates.
The present invention relates to polymers which contain spirotruxene derivatives as the repeating units, to methods for their production, and to their use in electronic devices, especially in organic electroluminescent devices, so-called OLEDs (organic light emitting diodes). The present invention also relates to organic electroluminescent devices which contain said polymers.
C08G 61/12 - Macromolecular compounds containing atoms other than carbon in the main chain of the macromolecule
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
C08L 65/00 - Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Compositions of derivatives of such polymers
C09D 165/00 - Coating compositions based on macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain; Coating compositions based on derivatives of such polymers
To provide a new crosslinked polysilazane making it possible to form a thick film and form a silicon-containing film good in crack resistance. A crosslinked polysilazane having a certain structure.
C09D 183/16 - Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers in which all the silicon atoms are connected by linkages other than oxygen atoms
Hdefdef] carbazoles, mixtures and formulations containing them, and electronic devices containing these compounds, in particular organic electroluminescent devices containing these compounds as matrix materials, electron-transport materials or hole-blocking materials.
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
Provided is a thick film chemically amplified positive type resist composition. A thick film chemically amplified positive type resist composition comprising a certain alkali-soluble resin (A), a photoacid generator (B), and a certain solvent (C).
Provided is a thick film chemically amplified positive type resist composition. A thick film chemically amplified positive type resist composition comprising an alkali-soluble resin (A) having a certain structure, a photoacid generator (B), and a solvent (C).
The disclosed and claimed subject matter relates to copper (Cu), zinc (Zn), cadmium (Cd), magnesium (Mg), calcium (Ca), strontium (Sr) and barium (Ba) compounds and methods of using the compounds as precursors for deposition of metal-containing films.
C23C 16/18 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the deposition of metallic material from metallo-organic compounds
The invention relates to substituted bi- and tricycles of the general formula (I),and the use of the compounds of the present invention as inhibitorsof HSET for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
C07D 417/10 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
C07D 417/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
The present invention relates to a method for identifying a pharmaceutically or cosmetically active compound that modulates the rpL40-dependent translation of at least one mRNA encoding for tropoelastin in a mammalian cell. Furthermore, a respective screening system, methods of treating or preventing a disease or condition, and compounds as identified that modulate the rpL40-dependent translation as well synergistic combinations thereof are provided. In a preferred aspect, the cosmetically active compound is used in anti-aging products and strategies.
C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
The present invention relates to compounds that can specifically activate TLR7. The compounds of the invention are useful because they can stimulate innate immunity. The compounds of the invention can be used in the treatment of conditions including cancer, viral infections and skin lesions. The compounds can optionally be formulated for enhanced penetration following topical administration, said composition preferably initiating a local specific inflammatory cytokine response while limiting undesirable erythema and other inflammatory reactions. The invention also relates to pharmaceutical compositions comprising the compound of the invention and preferably an additional compound such as imiquimod and/or resiquimod (R848). The invention also relates to a composition comprising a compound of the invention and to a compound for use as a medicament. Other aspects, embodiments, advantages and applications of the invention will become clear from the further description herein.
A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
59.
USE OF IFN-I ACTIVITY AS A BIOMARKER FOR TLR INHIBITOR TREATMENT
The present invention provides for the use of IFN-I activity as a predictive biomarker for the treatment of patients with toll-like receptor (TLR) inhibitors and related uses and methods.
C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
A61P 37/00 - Drugs for immunological or allergic disorders
G01N 33/68 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
G01N 33/564 - Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease
60.
DSA OF LIQUID CRYSTAL BLOCK COPOLYMERS FOR INTEGRATED CIRCUIT PATTERNING
233 is selected from a C-3 to C-8 linear alkyl, R' is H or a C-3 to C-8 linear alkyl wherein said block copolymer has a poly dispersity of 1 to about 1.31. Also described are compositions of this block copolymer in a solvent and their use in DSA processing.
C08F 293/00 - Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
B05D 1/00 - Processes for applying liquids or other fluent materials
C09D 153/00 - Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
H01L 21/00 - Processes or apparatus specially adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
C08F 297/02 - Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer using a catalyst of the anionic type
61.
THERMOSTABLE VACCIN FORMULATIONS AND PROCESS FOR PREPARING THE SAME
The present invention relates to the use of melezitose to improve thermostability of a dry protein formulation, a process for increasing the thermostability and thermally stabilized dry protein formulations. More specifically, the present disclosure relates to the use of melezitose for increasing thermostability of a dry vaccine formulation.
Described is a patterned liquid crystal monolayer structure (100) on a patterned substrate (900), wherein said patterned substrate is comprising surface areas which grafted onto (500) by a liquid crystal compounds (300) as a self-assembled monolayer (SAM) (200) and surface areas which are not grafted onto (400) by this SAM on this patterned substrate. Also described, are compositions of select liquid crystal (200) with different types of polar anchor groups, in an organic spin casting solvent and the method of using this composition to selectively deposit a SAM on a substrate containing both metallic surface areas and non-metallic inorganic silicon compound surface areas on either one of these areas, depending on the nature of a polar anchor group on the liquid crystal compound, and using this selective SAM deposition as a barrier to selectively deposit a metal oxide dielectric by ALD on the area not grafted by a SAM.
H05K 3/12 - Apparatus or processes for manufacturing printed circuits in which conductive material is applied to the insulating support in such a manner as to form the desired conductive pattern using printing techniques to apply the conductive material
H10K 71/12 - Deposition of organic active material using liquid deposition, e.g. spin coating
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/14 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
63.
NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to nitrogenous heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
H10K 85/00 - Organic materials used in the body or electrodes of devices covered by this subclass
C07F 9/6584 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
The present invention relates to an electronic device comprising at least at least two subpixels, where the subpixels comprise a common hole-transport layer c-HTL and different electron-blocking layers EBL1 and EBL2, where the interface charge density ICD at the interface of c-HTL / EBL1 and c-HTL / EBL2, fulfils specific criteria.
The present disclosure provides methods and systems for optimizing chemical reactions through machine learning. Chemical spaces are defined by grouping prospective chemicals based on selected features. Representative chemicals are selected from each group to assemble a test kit. The test kit is then used to identify the best catalyst or ligand for a catalytic chemical reaction. In some embodiments, the system can recommend a test kit, receive results from experiments, generate a distance matrix, and rank prospective chemicals based on scores obtained for their representative chemicals. The methods involve reducing the dimensionality of chemical features and normalizing distances. The disclosed embodiments can suggest prospective chemicals for optimizing chemical reactions by sorting them based on scores obtained from representative chemicals.
C08F 2/50 - Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
C08F 232/08 - Copolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system having condensed rings
C08G 61/08 - Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes only aliphatic carbon atoms prepared by ring-opening of carbocyclic compounds of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring
C09D 145/00 - Coating compositions based on homopolymers or copolymers of compounds having no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic or in a heterocyclic ring system; Coating compositions based on derivatives of such polymers
C09K 11/88 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
H05B 33/14 - Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material
H05B 33/20 - Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the material in which the electroluminescent material is embedded
68.
FILTRATION SYSTEM AND AUTOMATED FILTRATION PROCESS FOR TESTING LIQUIDS USING CONSUMABLE FILTRATION UNITS
The present invention relates to hydroxyamino phosphinic acid derivatives of formula (I) in which the occurring groups and parameters have the meanings defined in claim 1, to a method for their preparation and to their use for the fabrication of self-assembled monolayers (SAM), in particular for the fabrication of switchable SAM for electronic devices. The invention further relates to electronic devices comprising said SAM, preferably in the field of organic electronics, in particular for use in memory, sensors, furthermore in organic light-emitting diodes (OLEDs), photovoltaics (OPVs), field-effect transistors (OFETs) and Josephson junctions, very particularly in memristive components such as memristive crossbar-arrays.
C07F 9/655 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
H10K 85/00 - Organic materials used in the body or electrodes of devices covered by this subclass
C07F 9/6553 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
70.
SILICON PRECURSOR COMPOUND IN ASYMMETRIC STRUCTURE, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING A SILICON-CONTAINING THIN FILM
The present invention relates to a silicon precursor compound in an asymmetric structure containing an alkoxide capable of preparing a silicon-containing thin film with high quality, to a method for preparing the same, and to a method for preparing a silicon-containing thin film using the silicon precursor compound in an asymmetric structure containing an alkoxide.
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition (CVD) processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
The present invention relates to a metal complex, a formulation comprising metal complex and a method for preparing a metal oxide optical layer using said formulation and metal complex. The obtained metal oxide optical layers are particularly suitable for applications in optical devices such as, for example, in augmented reality (AR) and/or virtual reality (VR) devices.
The invention relates to an optical component exhibiting a reverse or negative optical dispersion profile comprising two or more liquid crystalline polymer films, wherein the first utilized polymer film exhibits a uniform planar alignment of the polymerised LC molecules and the second polymer film adjacent to the first polymer film exhibits a cholesteric alignment of the polymerised LC molecules having a ¼ pitch rotation through the film thickness of the second polymer film. Furthermore, the present invention relates also to a method for its preparation. These optical components may be used for purposes suh as, for example, adjusting optical properties of a liquid crystal display (LCD), improving light utilization efficiency, or ensuring anti-reflectivity and visibility in an organic light emitting device (OLED), or even for AV/VR applications. Accordingly, the invention relates further to the use of such optical components for optical, electro-optical, decorative or security applications and to corresponding devices as such.
The present invention relates to nitrogen-containing heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
The present invention relates to nitrogen-containing compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
The invention relates to a method for producing indolo[3,2,1-jk]carbazole and derivatives by reacting a compound of formula (1) and at least one nitrosyl cation source.
The present invention relates to the use of polyvinyl alcohol for spray-drying to form an amorphous solid dispersion of an active pharmaceutical ingredient in a polyvinyl alcohol matrix. Furthermore, the invention relates to a process for producing an amorphous solid dispersion of an active pharmaceutical ingredient in a polyvinyl alcohol matrix by spray-drying.
The invention relates to a polymerizable LC material comprising one or more reactive mesogenic compounds and one or more compounds of formula (I), wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film obtainable from a corresponding polymerizable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerizable LC material in optical, electro-optical, in particular electrooptical devices in the field of augmented or virtual reality.
The disclosed and claimed subject matter provides precursors having at least one tethered cyclopentadienyl ligand ("Cp ligand"), at least one amidinate ligand ("Ad ligand") and a lanthanide and/or lanthanide-like transition metal ("M") of the general formulae (i) (Cp ligand)2-M-(Ad ligand) or (ii) (Cp ligand)-M-(Ad ligand)2.
The invention relates to a polymerizable LC material comprising one or more reactive mesogenic compounds and one or more compounds of formula I, (R12mnn I wherein the individual radicals have one of the meaning as given in the claims. Furthermore, the present invention relates also to a method for its preparation, a polymer film obtainable from a corresponding polymerizable LC material, to a method of preparation of such polymer film, and to the use of such polymer film and said polymerizable LC material in optical, electro-optical, decorative or security devices, in particular in optical or electrooptical devices in the field of augmented or virtual reality.
The invention relates to substituted bicycles of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
C07D 413/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
The application relates to the use of an antibody molecule that binds to MSLN and CD137 and a PD-1/PD-L1 inhibitor in the treatment of cancer in a patient.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
84.
CANCER TREATMENT COMPRISING AN ANTI-MSLN/CD137 ANTIBODY AND A CHEMOTHERAPEUTIC
The application relates to the use of an antibody molecule that binds to MSLN and CD137 and a chemotherapeutic in the treatment of cancer in a patient.
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
G03F 7/027 - Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
G03F 7/038 - Macromolecular compounds which are rendered insoluble or differentially wettable
G03F 7/105 - Photosensitive materials - characterised by structural details, e.g. supports, auxiliary layers having substances, e.g. indicators, for forming visible images
G02B 1/00 - Optical elements characterised by the material of which they are made; Optical coatings for optical elements
G02F 1/00 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
C09D 4/06 - Coating compositions, e.g. paints, varnishes or lacquers, based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups
C08F 2/48 - Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
C09D 151/00 - Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
The present invention relates to effect pigments and multilayer films from two or more biodegradable polymer layers having different refraction indices and in alternating order, a method for producing them, and to their use, inter alia, in cosmetic products, rinse-off products, packaging materials, decorative films, paints, printing inks and plastics.
The present invention relates to a process for the preparation of a solid pharmaceutical administration form comprising an amorphous solid dispersion using a 3D printing process. The process is a printing process that allows the production of a solid pharmaceutical solid administration form comprising an amorphous solid dispersion in an easy and flexible manner and the possibility to achieve fast disintegrating dosage forms with high drug loads.
1111 are non-polar block copolymer segment comprising styrenic repeat unit, E', E'' E3and E42gg of about -5°C to about -50°C, and in structure (I) is multi-tethered with oligo flexible tethered groups at various positions as outlined. E'-A-L-B-E'' (I) E312111-E4 (III)
C08F 293/00 - Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
B82Y 40/00 - Manufacture or treatment of nanostructures
C08F 297/02 - Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer using a catalyst of the anionic type
C09D 153/00 - Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
H01L 21/00 - Processes or apparatus specially adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
The present invention relates to diazadibenzofuran derivatives and diazadibenzothiophene derivatives and to electronic devices containing said compounds, in particular organic electroluminescent devices containing said compounds in the form of triplet matrix materials, optionally combined with another triplet matrix material and suitable phosphorescent emitters, and to suitable mixtures and formulations.
3p4p3p3p3p3p4p4p cannot respectively, both simultaneously, be moieties of structure (IIIp) and (IVp), simultaneously be moieties of structure (IIIp) and (IVp1), or simultaneously be moieties of structure (IIIp) and (IVp2). The polymer of structure (A) must contain, one grafting end group moiety selected from structures (IIIp), (IVp), (IVp1) or (IVp2). Composition of this with a solvent are used in DSA processing.
C08F 4/08 - Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen of alkali metals
The present invention relates to diazadibenzofuran derivatives and diazadibenzothiophene derivatives and to electronic devices containing these compounds, in particular organic electroluminescent devices containing these compounds in the form of matrix materials, optionally in combination with a further matrix material and suitable phosphorescent emitters, and suitable mixtures and formulations of said compounds.
The present invention relates to novel compounds having valuable properties, in particular those which can be used for the preparation of medicaments as well as methods of their use and manufacture. Said compounds are particularly useful as PI4K inhibitors and for the treatment or prevention of PI4K-related disorders such as protozoan infections like malaria and virus infections.
The present invention relates to a heterocyclic compound of formula (1) as well as compositions and devices comprising these compounds, especially organic electroluminescent devices comprising these compounds as host materials.
The present invention relates to novel compounds having valuable properties, in particular those which can be used for the preparation of medicaments as well as methods of their use and manufacture. Said compounds are particularly useful as PI4K inhibitors and for the treatment or prevention of PI4K-related disorders such as protozoan infections like malaria and virus infections.
The present invention relates to liquid compositions comprising a nucleic acid having a reduced viscosity. Furthermore, the invention relates to methods for reducing the viscosity of a liquid compositions comprising a nucleic acid.
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
97.
NOVEL CRYSTALLINE FORMS OF (S)-7-OXA-2-AZA-SPIRO[4.5]DECANE-2-CARBOXYLIC ACID [7-(3,6-DIHYDRO-2H-PYRAN-4-YL)-4-METHOXY-THIAZOLO[4,5-C]PYRIDIN-2-YL]-AMIDE AND CO-CRYSTAL FORMS THEREOF
The invention relates to novel crystalline forms of (S)-7-Oxa-2-aza-spiro[4.5]decane-2-carboxylic acid [7-(3,6-dihydro-2H-pyran-4-yl)-4-methoxy-thiazolo[4,5-c]pyridin-2- yl]-amide, processes for their preparation, medicaments and pharmaceutical preparations comprising these forms.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
A61K 31/4365 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
The invention relates to a method (100) for filling liquid crystal cells (40) with a medium (30) comprising at least one liquid crystalline material. The liquid crystal cells (40) comprise two substrates (42) joined together with a peripheral seal (44) so that a cavity (43) is formed, wherein the liquid crystal cells (40) comprise at least one fill opening (46). In a first step a) of the method (100) at least one liquid crystal cell (40) is placed (A) inside a vacuum chamber (12). In a subsequent step b) the vacuum chamber (12) is evacuated (B). After evacuation has been completed, the at least one fill opening (46) of the at least one liquid crystal cell (40) is contacted (C) with the medium (30) in a step c). In a subsequent step (D) the pressure in the vacuum chamber (12) is raised to an overpressure, wherein the rising pressure in the vacuum chamber (12) causes the medium (30) to fill (E) the cavity inside the at least one liquid crystal cell (40). Further aspects of the invention relate to an apparatus (10) for filling a liquid crystal cell (40) with a medium (30) comprising at least one liquid crystalline material, and to a computer readable medium (23) comprising a computer executable routine configured to perform at least one step of a method (100) according to the invention. The invention further relates to liquid crystal cells (40) obtainable by the method (100), in particular window elements for applications in buildings and vehicles with energy savings and improved comfort.
G02F 1/13 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
The present invention relates to a composition containing a light emitting moiety such as quantum materials incl. quantum dots; and a process for fabricating the composition.
A cap having a closed end and one or more openings is attached to the tip of an optical Raman probe sensor. The cap serves to block stray light noise from entering the tip of the sensor. In this way, Raman spectra may be more accurate and consistent. Further, the cap may be permanently affixed or removably attached to the sensor. In some embodiments, a reflective surface may be included on the interior surface of the closed end of the cap. This reflective surface may reflect Raman scattering light toward the tip, enhancing the received signal by a factor of 2 to 100.
patents
